to sacrifice a healthy nerve, resulting in neuropathic pain and donor site morbidity, and several groups have succeeded in deriving Schwann cells from bone marrow mesenchymal stem cells, adipose stem cells, and skin precursor (SKP) cells. 2, 9, 10, 17, 21, 26, 42 Prior in vivo experiments from our group and others show some histological improvement after stem cell/Schwann cell therapies; however, the evidence for functional peripheral nerve recovery remains limited. 16, 47, 48 In the present study, we aimed to evaluate the potential of SCs derived from the isogenic nerve and skin precursors for improved sensory recovery in a standard sciatic nerve transection model.
Methods

Cell Isolation and Culture
Schwann cells were isolated from sciatic nerves of P2 Lewis rats according to established protocols 22, 47 with minor modifications. Briefly, sciatic nerves were excised, stripped of the epineurium, and cut into 1-mm 2 pieces. Nerve segments were placed on poly-d-lysine-coated 35-mm culture dishes in DMEM/F12 medium supplemented with 10% FBS, 1% penicillin/streptomycin, and 0.25 mg/ ml Fungizon for 3 days, allowing fibroblast migration out from the nerve. The medium was then changed to serumfree DMEM containing 1% N2, 10 ng/ml heregulin-1b, 4 mM forskolin (Schwann cell medium [SC medium]) for another 3 days to stimulate Schwann cell outgrowth. At Day 6, fragments were removed from the dish and explanted onto another 35-mm dish in SC medium with 2.5% FBS. The explant procedure was repeated until little outgrowth of fibroblasts was observed, then the explants were discarded and all dishes containing Schwann cells were purified in serum-free SC medium. Purity of nerve Schwann cell (nSC) cultures was assessed by p75 and GFAP immunolabeling and a heregulin exclusion test. 35 Skin-derived precursor (SKP) cells were obtained from dermis of postnatal Day 2 Lewis rats and cultured according to published protocols. 6, 46, 47 Briefly, skin from the dorsal torso was minced in HBSS (Gibco) on ice, incubated for 45 minutes in 0.1% collagenase XI at 37°C, dissociated mechanically, washed in cold DMEM, and passed through a 40-mm cell strainer. Filtrate was centrifuged at 1200 rpm, and the pellet was triturated and resuspended in culture medium (DMEM:F12 3:1, 100 U/ ml penicillin and 100 mg/ml streptomycin, 0.25 mg/ml Fungizon, 1× B27 supplement, 20 ng/ml EGF, and 40 ng/ ml bFGF [all from Gibco]). Skin-derived precursor cells were cultured and passaged as undifferentiated spherical aggregates at 37°C in a humidified atmosphere containing 5% CO 2 /95% air.
The progenitor state of the cells within the aggregates was confirmed with nestin immunolabeling. To induce differentiation toward Schwann cells, aggregates were triturated and replated on poly-d-lysine/laminincoated culture dishes (Corning) in SC medium (DMEM/ F12 supplemented with 100 U/ml penicillin and 100 mg/ ml streptomycin, 0.25 mg/ml Fungizon, 4 mM forskolin, 10 ng/ml heregulin-1b, and 1% N2 supplement [Gibco]), as described. 6, 40 Media were changed every 3-4 days. 
In Vitro Myelination
To confirm the myelinating properties of cultured cells, SKP-SCs and nSCs were seeded onto the neurite network formed by 1-week culture of dorsal root ganglia from postnatal (P10) Lewis rats in Neurobasal medium containing B27 supplement, 10% FBS, 50 ng/ml NGF, 1% penicillin/streptomycin and 0.25 mg/ml Fungizon. Assay was performed in 8-well chamber slides (Nunc) coated with Matrigel. Host Schwann cells from dorsal root ganglia were killed by the addition of 7 mM cytosine arabinoside. Nerve Schwann cells (nSCs) and SKP-SCs were labeled with CellTracker CM-DiI (Invitrogen) prior to seeding. Co-cultures were maintained in SC medium containing 50 ng/ml NGF, and ascorbic acid (50 mg/ ml, Sigma) was added to induce myelination. 42 The coculture was maintained for 2 weeks, then fixed with 2% paraformaldehyde (PFA) in PBS, blocked/permeabilized with 2% BSA/ 0.3% Triton-X100 in PBS and stained for myelin basic protein (MBP) with secondary antibodies with an emission wavelength of 488 nm.
Animals
A total of 27 male Lewis rats weighing 225-250 g (Charles River) were used in this study (as detailed below). Animals were maintained in a temperature-and humidity-controlled environment with a 12-hour light/dark cycle. Food (Purina) and water were available ad libitum. Surgical interventions were carried out under inhalation anesthetic (Isoflurane, 99.9%, Halocarbon Laboratories), and pain control was provided by means of intraperitoneal or oral administration of buprenorphine (30 mg/kg). Surgical procedures were carried out aseptically, and standard microsurgical techniques were used with an operating microscope (Wild M651; Wild Leitz). Animals were killed at endpoint under deep anesthesia using an overdose of intracardiac Euthanol (Bimeda-MTC). All efforts were made to minimize suffering and animal numbers by using appropriate protocols. The protocol was approved and monitored by the University of Calgary animal care committee and adhered strictly to guidelines set by the Canadian Council on Animal Care.
Surgical Procedures
Surgery was performed unilaterally, in the right hindlimb, in all animals. The sciatic nerve was exposed at mid-thigh level after splitting the biceps femoris muscle and transected ~ 1 cm proximal to the trifurcation with a small segment removed to create a 5-mm gap. All animals received an immediate entubulation repair within a silicon tube, inner diameter 1.5 mm, secured with 9-0 Prolene microsutures at each end, leaving a 5-mm gap between the proximal and distal stumps, using previously reported techniques. 19, 38 Immediately following repair, 10 ml of nSCs (n = 6) or SKP-SCs (n = 5) or carrier medium (n = 6) was injected using a 10-ml Hamilton syringe with a 30-gauge needle into the segment of transected sciatic nerve immediately distal to the graft, giving a total of 1 × 10 6 cells. Schwann cells were labeled 20 minutes prior to injection with CellTracker CM-DiI (Invitrogen) according to the manufacturer's guidelines. Briefly, cells were trypsinized from culture vessels and resuspended to 1 × 10 6 cells/ml in medium containing 1 mM DiI staining solution. Following incubation for 20 minutes in the dark, cells were washed 3 times in DMEM and stored on ice until injection. To monitor cell/medium delivery, 0.1% FastGreen was added to the cells and medium immediately before injection. In a non-repair group (n = 5), severed nerve was not repaired and no injections were made. In a sham-surgery group (n = 5), nerve was exposed but not operated. Wounds were closed in layers, and the animals were housed as described above with appropriate analgesic administration (4 days), until they were killed at the 11-week time point.
Electrophysiology
Electrophysiological recovery was assessed by measuring compound muscle action potential (CMAP) amplitude and latency. Electrical conductivity across the injury site was evaluated by stimulating the sciatic nerve proximally (at the sciatic notch) and measuring the CMAP amplitude evoked in the gastrocnemius muscle 5 and 8 weeks following the surgery. Animals were anesthetized with isoflurane as described above, stimulating bipolar electrodes were inserted percutaneously into the sciatic notch proximal to the nerve repair site, and a supramaximal stimulus was delivered to the sciatic nerve. Recording electrodes were placed longitudinally into the gastrocnemius muscle, and the ground electrode was placed subcutaneously in the base of the tail. Recordings were obtained using a VikingQuest electrodiagnostic system (Nicolet). The distance between the electrodes was measured, and latencies were used to calculate nerve conduction velocity (NCV).
Thermal Sensitivity Testing
Sensory recovery of the experimental animals was evaluated by analyzing the responses of injured and contralateral intact hindlimbs to thermal stimulus by the Hargreaves plantar test according to published methods.
13,52,53
The animals were placed in a Plexiglas chamber atop a transparent glass surface that housed a radiant heat source and acclimatized for 5 minutes. The heat source was placed directly under the plantar surface of the hind paw and activated, starting a digital timer. The time count stopped when the paw was withdrawn from the heat source, indicating the paw withdrawal latency (seconds).
Three or four evaluations for each paw were performed by an observer blinded to the nature of the groups. Intervals of 5 minutes were allowed between the readings to prevent paw sensitization, and withdrawal latency of the injured (right) limb was normalized to the uninjured side to generate latency ratio. Baseline levels were established 1 week before the injury/cell injection. Sensitivity testing resumed 4 weeks after surgery and was also performed at weeks 7 and 10 postinjury.
Target Muscle Weight
As the animals were killed at the 11-week time point as described above, the gastrocnemius muscles were immediately exposed and dissected bilaterally. Muscles were explanted accurately to prevent excessive bleeding, and the wet muscle weights were recorded. Muscle weights were normalized to the contralateral side to account for individual differences between animals.
Immunohistochemistry
At 11 weeks following surgery and cell implantation, nerve segments immediately distal to the injury site were excised, removed carefully from silicon tubes, and fixed overnight in 2% PFA in PBS. Samples were washed three times in PBS, cryoprotected in 30% sucrose, and embedded in optimal cutting temperature (OCT) compound (Sakura Fine technical Co.). Longitudinal sections 12 mm in length were cut with a cryostat (Leica Microsystems Inc.) at −23°C and mounted on Superfrost slides (Fisher Scientific). Sections were blocked/permeabilized with 2% BSA/0.3% Triton-X100 in PBS and incubated overnight in primary antibody. Antibodies used were antineurofilament NF200 (1:500, from Sigma) and FITC-IB4 (1:100, from Vector Laboratories). Following 3 washes with PBS, NF200-labeled slides were incubated with secondary antibody (Alexa Fluor anti-mouse IgG 488) for 3 hours. Slides were then washed and cover-slipped using Fluorosave reagent (Calbiochem) and viewed under a fluorescence microscope (Olympus BX51). Omission of primary or secondary antibody was used as negative control for the staining process. On average, 5 or 6 sections were stained for each regenerating nerve, and in each of these sections, a line was drawn perpendicular to the center of the section and antibody-positive profiles crossing this line were counted and summed, similar to previously described methods. 18 
Statistical Analysis
Differences between groups were analyzed using a 1-way ANOVA with a post hoc t-test. Statistical significance was accepted at p < 0.05 for pairwise comparisons. All results are presented as the mean ± SEM
Results
Cells
Our first aim was to confirm phenotypic stability of nSCs and SKP-SCs after isolation from nerves or differentiation from dermis stem cells. Both cell types retained characteristic Schwann cell morphology and were positive for p75 neurotrophin receptor, a canonical Schwann cell marker, 30, 47 after purification and expansion in culture ( Fig. 1 and B ). An in vitro myelination assay further demonstrated that both nSCs and SKP-SCs formed robust and abundant myelination profiles when seeded on dorsal root ganglion neurite network, evidence that purification and in vitro culture did not impair Schwann cells' ability to myelinate (Fig. 1C and D) . In the case of SKP-SCs, in vitro myelination testing also further confirmed successful differentiation of SKP cells into functional Schwann cell analogs. Expanded cells were next used for injections into transected rat sciatic nerves.
Surgeries
All operated animals survived the surgeries, the operations were well tolerated, and wounds healed without signs of infection, pain, or discomfort. A total of 1 × 10 6 cells or 10 μl of medium alone was used for injection into transected sciatic nerve, as described in Methods. The intraoperative spread of cell/medium injection was monitored with Fast Green and was typically observed from the injection site to 1-1.2 cm distal, confined within the nerve with no significant leakage outside. Graft repair remained intact and regenerating cables formed in all repair groups across the prior injury and repair site, characterized by areas of irregular fibers of connective tissue, invading macrophages, Schwann cells, debris, and regenerating axons. Interestingly, DiI-positive cells were observed 11 weeks postsurgery in both the nSC and the SKP-SC injection groups. This may not necessarily be a characteristic of cell survival (since the lipophilic dye may dilute when cells divide or myelinate 37 ), but the finding definitely suggests that DiI CellTracker has a potential for effective long-term labeling (Fig. 1E and F) .
Electrophysiology
After the surgery the electrophysiological parameters (CMAP amplitude and NCV) were decreased at Weeks 5 and 8 in all injury groups in comparison with findings in the sham-surgery group, with the non-repair group predictably showing the lowest values. The cell therapy groups demonstrated a trend toward improved electrophysiological recovery, with the SKP-SC group being the only repair group to reach significant difference in NCV from non-repair by Week 8 after injury (p < 0.05).
In agreement with our previous data, 47 peak CMAP amplitude measurements also revealed a trend for improved recovery in the SKP-SC group (Fig. 2) . However, the advantage of this group's amplitude versus other operated groups did not reach statistical significance in this study. 
Thermal Sensitivity
In our sciatic nerve transection model, all injury groups developed, by Week 4, a significant decrease in sensitivity to thermal stimulation in the injured hind paw (p < 0.01) compared with baseline levels. This hypoalgesic state remained significantly higher compared with baseline in non-repair and medium groups at all time points analyzed and until the end of experiment (p < 0.01). However, cell therapy with 1 × 10 6 of either nSCs or SKP-SCs markedly reversed thermal responses to a normalgesic level, which was no longer significantly different from the baseline (p > 0.05) by Week 10 (Fig. 3) .
Target Muscle Weights
To analyze potential myotrophic effects of cell therapy in our injury model, we weighed the gastrocnemius muscles 11 weeks after surgery and normalized them to their respective contralateral (left) sides to compare with the denervated controls (non-repair group) and shamoperated animals. Weights of the muscles in all repair groups were approximately 41%-44% of the uninjured side, significantly (p < 0.001) higher than in the non-repair group (12% of normal). The differences between the repair groups were, however, not significant (Fig. 4) .
Axonal Regeneration
To anatomically confirm our findings on sensory recovery, regenerated nerves were excised at the termination time point (Week 11), fixed in PFA, and sectioned longitudinally, as described above. Axonal outgrowth was analyzed distal to the injury site by immunohistochemistry for isolectin B4 (IB4) as a robust and specific marker of the sensory neuron subpopulation and for neurofilament NF200 as a more general marker. Both NF200 and IB4 immunohistochemistry revealed prominent regenerative improvement in both cell therapy groups (30%-70% increase in NF+ profiles and 70%-110% in sensory-specific IB4 staining in cell therapy groups compared with the medium alone group, Fig. 5 ).
Discussion
Cell therapies with Schwann cells and other cell types have gained increased attention in recent years as a potent tool to improve the outcomes of nerve recovery beyond those achieved with the current gold standarddirect microsurgical repair. 25, 29, 33, 34, 49, 55 It has been found that pre-differentiation of stem cells into the Schwann cell phenotype in vitro prior to injection results in remarkably better outcomes compared with the use of undifferentiated SKPs or mesenchymal stem cells. 16, 47, 48 In previous studies, we and others showed that SKPs, predifferentiated in vitro into Schwann cells (SKP-SCs), survived in vivo and promoted robust axonal regrowth both in vitro and in acute and chronic models of rodent nerve injury. 5, 47, 51 In the present study, we therefore moved on to assess the effects of nSC and SKP-SC therapy on the functional sensory recovery of an injured limb.
Transection (Grade V) nerve injury results in a dramatic deficit in both motor and sensory functions of the injured limb. 1, 29, 54 Observed changes in thermal responses vary from hyperalgesia in less severe to hypoalgesia in more severe injuries.
14 In our study, non-repair and medium-treated groups predictably became hypoalgesic after injury and remained so until the end of the experiment (as late as Week 10 postsurgery). Present time points for the regeneration analysis were based on our earlier observations of peripheral nerve regeneration after transection injury. 19, 20, 47 In sharp contrast to the medium injection group, animals that received cell therapy showed by Week 10 clear signs of return to the normalgesic state according to a standard Hargreaves plantar test. The SKP-SC group showed maximum recovery potential, which was, however, closely followed by the nSC group. Reduced response latencies in the cell therapy groups were paralleled by increased signal conduction velocity, as showed by standard electrophysiological tests. 19, 47 Normalized thermal response latencies for the cell therapy groups were restored to levels indistinguishable from the pre-surgery baseline, but did not extend beyond normal thermal response to hyperalgesic state.
To complement our sensory response data histologically, immunohistochemical analysis was performed on nerve longitudinal sections using IB4 from Griffonia (Bandeiraea) simplicifolia, a long-known marker for sensory neurons in the peripheral nervous system.
31,45
IB4 binds Ret tyrosine kinase 7 which controls a number of ion channels (Nav1.8, Nav1.9, Trp family) and receptors (delta opioid, Mrg family) critical for the detection and transduction of sensory signals.
12 IB4 was ranked the most specific and predictive marker of nociceptive C fibers, while NF200 is expressed in both A and C fibers. Our immunohistochemical data suggest that cell therapy is highly beneficial for the successful regrowth of sensory IB4+ neurons, being (especially in the case of SKP-SCs) a part of a more general regenerative improvement (Fig.  5 ). This histoanatomical finding is well in line with our observations on electrophysiological and thermal sensation recovery.
Our data on target muscle recovery/preservation suggest that cell therapies with either nSCs or SKP-SCs in the present injury model are apparently not additive to microsurgical repair. This is in contrast to our earlier findings in a chronic denervation model 50 and the work of others, 16 but the difference can be explained by the more severe degree of injury in the chronic model and in the work of Keilhoff et al., 16 leading to a more pronounced deficit in the no-cell group. Ipsilateral/contralateral ratios in Keilhoff's cell therapy groups remained around 40%, consistent with our study (Fig. 4) . Of note, cell therapy did not show any improvement in mechanical sensitivity (von Frey filament test) in our injury model (our unpublished observations; interestingly, thermal but not mechanical sensory recovery was also shown in a neuropathic pain model
53
). Assessment of skilled locomotion using the ladder-rung technique 19,27,28 also did not reveal a significant additive effect of cell therapy after sciatic nerve transection, but we found a noticeable improvement with SKP-SC treatment in a tibial nerve repair model. 20 Observed differences in recovery between small and large peripheral nerves may lead to a better understanding of regenerative potential span for stem cell therapies.
Contribution of nSCs and SKP-SCs to the regenerative process may result from a variety of effects, being very likely a convergence of many. The most obvious effects would be a competent myelination of the regenerating axons, together with the enhancement of Wallerian degeneration and accelerated clearance of inhibitory debris. 30 Injected nSCs and SKP-SCs may also release a variety of growth factors and other molecules supportive for axonal regeneration and the remodeling of the microenvironment. SKP-SCs were previously shown by our lab to produce increased amounts of NGF, NT-3 and BDNF. 47 This may also imply the cooperation of exogenous nSCs and SKP-SCs with the host cells. Schwann cells and their stem cell-derived counterparts may recruit into the injury site cells of other types that participate in debris clearance and tissue reconstruction and revascularization. 48, 49 The major novel findings in our study are: 1) Cell therapy with the use of nSCs and SKP-SCs is highly additive to (enhances) the regrowth of IB4+ sensory neurons as well as general regeneration of NF+ axons. 2) SKP-SCs and naïve Schwann cells facilitate paw sensory recovery in the regenerating sciatic nerve in an 11-week time frame. 3) SKP-SCs support functional recovery in peripheral nerve to an extent equal to or higher than achieved with nSCs. Our data therefore add to the evidence for significant potential of SKP-SCs as a tool for cell therapies in reconstructive neurosurgery.
